Skip to content

Public FDA record

Z-1739-2014: NaturaLyte Liquid Bicarbonate Concentrate, 6.4 liter bottle to be used with a hemodialysis unit; Part Num

Recall record Z-1739-2014 for Fresenius Medical Care Holdings, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1739-2014
Company in FDA record
Fresenius Medical Care Holdings, Inc.
FDA classification date
Jun 9, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class III

Reason stated in the source

Container cap may contain foreign material- 0.60% - 0.80% Manganese

Source facts

Action
Fresenius Medical notified customer by letter dated 5/1/14 to examine stock immediately and instructed to discontinue use and place all Naturalyte Liquid Bicarbonate Concentrate in a secure area for return to FMC-RTG. The customer instructed to contact the Fresenius Medical Care Customer Service Team for instructions on how to return the recalled product.
Initiated
2014-05-01
Root cause
Equipment maintenance
Terminated
2016-06-15
Distribution
Distributed in the state of MO.
Recall number
Z-1739-2014
Recall status
Terminated
CDRH record ID
127081
FDA classified
2014-06-09
Recall event number
68135

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗